Lavie Bio
Lavie Bio, a subsidiary of Evogene Ltd., aims to improve food quality, sustainability, and agriculture productivity by introducing microbiome-based ag-biological products. Lavie Bio utilizes a proprietary computational predictive platform, the BDD platform, powered by Evogene’s proprietary MicroBoost AI tech-engine, harnessing the power of big data, artificial intelligence, and advanced informatics for the discovery, optimization and development of bio-stimulant and bio-pesticide products.
Biologicals
Corteva, Lavie Bio Finalize $5 Million Deal for Exclusive AI-Aided Development of Biofungicide
The payment completes the $5M advance payment received under the licensing agreement for biofungicide product candidates.
Biologicals
Lavie Bio Forms Distribution Agreement with WinField United Canada for Its Bio-Inoculant Seed Treatment Yalos
The agreement supports Lavie Bio’s 2024 sales growth plan for spring wheat, durum, and barley in Canada.
Biologicals
Lavie Bio Expands Bio-Inoculant Product for Spring Wheat to Durum and Barley
Lavie Bio will offer Yalos to farmers growing spring wheat, durum and barley across the U.S. and Canada in 2024.
Biologicals
Lavie Bio Advances Biofungicide Toward Commercialization in U.S., Europe Trials
LAV321 delivered positive results in 2023 field trials across Europe and the U.S., protecting against downy mildew.
Latest News
Europe
ADAMA Introduces New Cereal Herbicide in Poland
EDAPTIS is also expected to be registered in multiple...
ABG Update Feature
Industry Insights: ADAMA CEO Steve Hawkins on Managing Overstock, Improving Cash Flow in 2024
ADAMA's Steve Hawkins shares how the company is strategizing...
ABG Update Feature
Intel on New Crop Protection and Adjuvant Opportunities Revealed at CPDA Conference 2024
One of the top opportunities is for companies to...
ABG Update Feature
Kynetec: What’s Driving the Brazilian Biologicals Market
Kynetec’s André Dias recently shared exclusive insights in his...